[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@RevShark
"Over the last six months SPACs have lost $XX billion. A group of XXX SPACs that closed mergers by mid-February have lost XX% of their combined value. At one point last month the pullback topped $XXX billion. @WSJ" @RevShark on X 2021-09-02 10:11:50 UTC 30.8K followers, XX engagements
"One of my top stocks for 2021 $BRGGF Bragg Gaming Group Announces Record Fourth Quarter and Full Year 2020 Results Full year revenue up XXXX% year over year; a XXXX% CAGR since FY 2018 Fourth quarter revenue up XXXX% from the comparable period in the previous year" @RevShark on X 2021-03-25 12:46:21 UTC 30.8K followers, XX engagements
"Traders Await the Fed and the Busiest Week of Second-Quarter Earnings The setup for a sell the news reaction persists but it might be too obvious to work right away even with Wall Street trading desks warning of looming risks" @RevShark on X 2025-07-25 11:49:23 UTC 30.8K followers, 4025 engagements
"Target prices are the biggest scam on Wall Street. Goldman Sachs $GS strategist David Kostin began 2025 with a year-end target of 6500 for the benchmark and then cut it to 6200 after stocks began slumping. That got slashed to 5700 in late March on rising recession risk. Since then Kostin has lifted his target twice to 6100 and earlier this month 6600" @RevShark on X 2025-07-22 11:05:35 UTC 30.8K followers, 2509 engagements
"$SRTS Receipt of MDSAP Certification for Sensus Healthcares Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts BOCA RATON Fla. Sensus Healthcare Inc. (Nasdaq: SRTS) a medical device company specializing in highly effective non-invasive minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions announces that its entire portfolio of superficial radiation therapy (SRT) systems including the SRT-100 SRT-100+ and SRT-100 Vision has received certification under the Medical Device Single Audit Program (MDSAP). This" @RevShark on X 2025-07-24 14:11:57 UTC 30.8K followers, 2242 engagements
"New All-Time Highs Pile Up and There's Hardly a Downtick to Be Found Even the bulls would like to see a little downside as we head into a busy week of earnings and the Fed" @RevShark on X 2025-07-26 11:29:20 UTC 30.8K followers, 2959 engagements
"All the big banks have beaten EPS so far but the reaction is very tepid. No chasing. $JPM $C $WFC $BLK $BK" @RevShark on X 2025-07-15 12:11:07 UTC 30.8K followers, 2343 engagements
"How I'm Playing the Sudden Reversal: Bitcoin Cannabis and Gaming The key here is bonds. $GBTC $CAN $GTBIF $CRLBF $TCNNF $GRWG $AGFY $MSOS $GNOG $ELYS $DKNG $BRGGF $ENGMF" @RevShark on X 2021-03-09 16:37:40 UTC 30.8K followers, XX engagements
"$HUMA Humacyte Announces First Symvess Sale to Military Treatment Facility" @RevShark on X 2025-07-23 13:20:41 UTC 30.8K followers, 3579 engagements
"The Only Thing Missing From This Bull Market A trade deal with Japan sends the market higher as investors await major earnings reports from Google and Tesla. But there's one thing absent in this strong market" @RevShark on X 2025-07-23 13:08:56 UTC 30.8K followers, 3898 engagements
"6 Steps to Stalking Great Stocks for Big Profits Stalking is a poor approach to romance but it can be very effective in trading and investing" @RevShark on X 2025-07-26 14:09:58 UTC 30.8K followers, 1355 engagements
"@SimonKi97967462 poorly written. I modified it" @RevShark on X 2025-07-24 12:48:53 UTC 30.8K followers, XX engagements
"Just rallied on this--UNITED STATES AND EUROPEAN UNION ARE REPORTEDLY CLOSE ON A XX% TARIFF DEAL - Financial Times" @RevShark on X 2025-07-23 15:59:37 UTC 30.8K followers, 1929 engagements
"This is what is hitting biotech today--- $IBB $BBH $REPL Wedbush 'surprised' by Replimune CRL downgrades to NeutralWedbush analyst Robert Driscoll downgraded Replimune to Neutral from Outperform with a price target of $X down from $XX after the company received a complete response letter from the FDA regarding RP1 in combination with nivolumab as a treatment for PD-1 refractory melanoma patients. Wedbush is "surprised" by the CRL citing Replimune's previous positive interactions with the FDA but says new Center for Biologics Evaluation and Research Director Vinay Prasad is clearly playing a" @RevShark on X 2025-07-22 13:59:23 UTC 30.8K followers, 2258 engagements
"One of my top picks for 2021. $BRGGF - Bragg Gaming Group announces intent to list on Nasdaq Stock Market" @RevShark on X 2021-03-29 12:25:41 UTC 30.8K followers, XX engagements